Influence of the Radiological Stage on the Efficiency of Viscosupplementation in Basal Thumb Arthritis
NCT03622736 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 122
Last updated 2018-08-09
Summary
The rhizarthrose is the most frequent affection of the hand at the age fifty and beyond. For the moderate forms of the disease, the majority of the studies recommend the recourse to the viscosupplement because of its efficiency in the long term.
On the other hand, no study was focused on the impact of the anatomical severity on the clinical result of the treatment by intra-articular injection of hyaluronic acid.
The present research has for objective to study the influence of the radiological severity on the result of the viscosupplement, in the conditions of daily practice, in patients affected by rhizarthrose.
It is an open observational multicentrical prospective study realized by 10 investigators rheumatologists and liberal orthopedic surgeons. The recruitment is competitive and the study will be ended when 55 patients will have been included by taking into account a risk of trial exits or of lost of sight of 10 %.The main criterion is the influence of the radiological stage on the answer to the treatment.
Duration of inclusion 6 months. Duration of follow-up 3 months. Total duration of the study 9 months.
Conditions
- Osteoarthritis Thumb
Sponsors & Collaborators
-
Labrha
lead INDUSTRY
Principal Investigators
-
thierry CONROZIER, MD · Labrha
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-03-31
- Primary Completion
- 2017-06-30
- Completion
- 2017-08-31
Countries
- France
Study Locations
More Related Trials
-
Effect of Subcutaneous Polyvidone Collagen Treatment on Hand Recovery in Adult Rheumatoid Arthritis.
NCT06656169 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of the Articular Microbiota in Rheumatoid Arthritis.
NCT04056234 ·Status: COMPLETED
-
A Study of The Effect of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate on Articular Damage in The Hand in Patients With Moderate to Severe Rheumatoid Arthritis Who Have an Inadequate Response to Non-Biological DMARDs
NCT01878318 ·Status: WITHDRAWN ·Phase: PHASE4
-
Multiple Ascending Doses of Rozibafusp Alfa (AMG 570) in Adults With Rheumatoid Arthritis
NCT03156023 ·Status: COMPLETED ·Phase: PHASE1
-
The Efficacy of Fecal Microbiota Transplatation on Axial Spondyloarthritis Patients Resistant to Conventional Treatment
NCT05654753 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Open-label Safety Extension Study of Gevokizumab in Erosive Osteoarthritis of the Hand
NCT02293564 ·Status: COMPLETED ·Phase: NA
-
AMG 162 (Denosumab) Phase 3 Study (DESIRABLE Study) in Participants With Rheumatoid Arthritis on Disease-modifying Antirheumatic Drugs (DMARDs) Treatment
NCT01973569 ·Status: COMPLETED ·Phase: NA
-
Filling Bone Erosions: a Longitudinal Multicentric HR-pQCT Study of Subcutaneous Tocilizumab in Rheumatoid Arthritis
NCT02765074 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of the Combination of Diacerein 100 mg Daily and MTX Versus MTX Alone in the Treatment of Early Rheumatoid Arthritis (RA)
NCT01264211 ·Status: COMPLETED ·Phase: PHASE2
-
Success of Tocilizumab in RA Patients With Remission Induction and Sustained Efficacy After Discontinuation
NCT01120366 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Sonographic Efficacy of Rituximab in Rheumatoid Arthritis
NCT01765374 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Tocilizumab in Patients With Rheumatoid Arthritis
NCT01187563 ·Status: COMPLETED
-
HiSCs in the Treatment of Rheumatoid Arthritis
NCT06947746 ·Status: RECRUITING ·Phase: NA
-
A 12 Week Study to Assess Changes in Joint Inflammation Using Ultrasonography in Patients With Rheumatoid Arthritis (RA)
NCT01292265 ·Status: TERMINATED ·Phase: PHASE3
-
Usability of an AI for M923 in Subjects With Moderate to Severe RA
NCT02722044 ·Status: COMPLETED ·Phase: PHASE3
-
Biomarkers in Rheumatoid Arthritis Treated With Anti-interleukin-6 Therapy
NCT04281602 ·Status: UNKNOWN
-
Evaluation Effects of Treatment With IL-6R Inhibitor on Clinical Response and Biomarkers in Patients With Rheumatoid Arthritis (RA) Not Responding to DMARDs and/or a First Biological Agent.
NCT01835613 ·Status: UNKNOWN ·Phase: PHASE4
-
Ultrasound Neuroimmune Modulation in Adults With Rheumatoid Arthritis
NCT07293871 ·Status: RECRUITING ·Phase: NA
-
The Role of Microbiome on Biological Therapy Efficacy in axSpA and RA
NCT04973787 ·Status: UNKNOWN
-
Intermetatarsal Bursitis in Patients With Rheumatoid Arthritis
NCT05698563 ·Status: TERMINATED ·Phase: NA
-
A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid Arthritis
NCT02287922 ·Status: COMPLETED ·Phase: PHASE2
-
Zoledronic Acid in Rheumatoid Arthritis
NCT02123264 ·Status: TERMINATED ·Phase: PHASE3
-
Safety and Effectiveness of Biological DMARDs in Elderly Patients With Rheumatoid Arthritis
NCT01685918 ·Status: UNKNOWN
-
Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1)
NCT01888874 ·Status: COMPLETED ·Phase: PHASE2
-
The Usability and Injection Time of the Physiolis Syringe and Autoinjector in Rheumatoid Arthritis Patients
NCT01163617 ·Status: COMPLETED ·Phase: PHASE2